Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBP
Classement en actions #38728
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise... Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Prix de l'action
$7.25
Capitalisation boursière
$836.45K
Changement (1 jour)
1.97%
Changement (1 an)
-98.45%
Pays
US
Échange Aspire Biopharma Holdings, Inc. (ASBP)

Catégorie

Healthcare
Le prix ASBP avec la capitalisation boursière de B
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
ASBP
$7.25
Capitalisation boursière de Aspire Biopharma Holdings, Inc.(ASBP)
Capitalisation boursière: $836.45K
En August 2026, Aspire Biopharma Holdings, Inc. a une capitalisation boursière de $836.45K. Cela fait de Aspire Biopharma Holdings, Inc. la 38728th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Aspire Biopharma Holdings, Inc. du 2022 au 2026
ASBP par rapport au top 5 des plus populaires stocks
Prix pour ASBP L’actif B La capitalisation boursière de B Résultats
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
$47,477,544 $836.45K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.478T +654,862,569.12%
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
$38,902,295 $836.45K
Apple Inc. Apple Inc.
AAPL
$4.488T +536,583,276.80%
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
$36,087,301 $836.45K
Alphabet Inc. Alphabet Inc.
GOOG
$4.163T +497,755,771.47%
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
$32,108,817 $836.45K
Microsoft Corporation Microsoft Corporation
MSFT
$3.704T +442,880,128.39%
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.
$24,628,922 $836.45K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.841T +339,709,166.10%